中医临床研究
中醫臨床研究
중의림상연구
CLINICAL JOURNAL OF CHINESE MEDICINE
2014年
15期
139-140,144
,共3页
趁疼散%骨转移瘤%唑来膦酸注射液%骨疼痛
趁疼散%骨轉移瘤%唑來膦痠註射液%骨疼痛
진동산%골전이류%서래련산주사액%골동통
Chenteng power%Bone metastasis%Zoledronic acid injection%Bone pain
目的:观察趁疼散联合唑来膦酸治疗转移性骨肿瘤的骨痛有效率、体力状况改善情况及不良反应。方法:31例恶性肿瘤骨转移患者服用趁疼散的同时采用联合唑来膦酸4mg加入0.9%氯化钠100mL静滴15min以上,每四周1个疗程,连用2个疗程。结果:治疗骨痛有效率为96.77%,体力状况改善率为64.5%,主要不良反应为发热,发生率为22.6%。结论:趁疼散联合唑来膦酸治疗恶性肿瘤骨转移疼痛有效,能显著改善患者的生存质量,不良反应少,可方便安全用于恶性肿瘤骨转移的治疗。
目的:觀察趁疼散聯閤唑來膦痠治療轉移性骨腫瘤的骨痛有效率、體力狀況改善情況及不良反應。方法:31例噁性腫瘤骨轉移患者服用趁疼散的同時採用聯閤唑來膦痠4mg加入0.9%氯化鈉100mL靜滴15min以上,每四週1箇療程,連用2箇療程。結果:治療骨痛有效率為96.77%,體力狀況改善率為64.5%,主要不良反應為髮熱,髮生率為22.6%。結論:趁疼散聯閤唑來膦痠治療噁性腫瘤骨轉移疼痛有效,能顯著改善患者的生存質量,不良反應少,可方便安全用于噁性腫瘤骨轉移的治療。
목적:관찰진동산연합서래련산치료전이성골종류적골통유효솔、체력상황개선정황급불량반응。방법:31례악성종류골전이환자복용진동산적동시채용연합서래련산4mg가입0.9%록화납100mL정적15min이상,매사주1개료정,련용2개료정。결과:치료골통유효솔위96.77%,체력상황개선솔위64.5%,주요불량반응위발열,발생솔위22.6%。결론:진동산연합서래련산치료악성종류골전이동통유효,능현저개선환자적생존질량,불량반응소,가방편안전용우악성종류골전이적치료。
Objective:To observation the effective rate, physical condition improvement and adverse reactions of pain of malignant tumor bone metastasis treated with Chenteng power and zoledronic acid. Methods:31 cases with malignant tumor bone metastasis were treated with Chenteng power while combined zoledronic acid 4mg 100mL 0.9%sodium chloride intravenous infusion over 15min, 4 weeks as a course, 2 courses in succession. Results:The effective rate was 96.77%in the treatment of bone pain, the improvement rate of physical condition was 64.5%, and the adverse reaction rate was 22.6% with the fever as the main adverse reaction.Conclusion: The Chenteng power combined with zoledronic acid in the treatment of pain of malignant tumor bone metastasis is effective which can significantly improve the life quality of patients and reduce the adverse reactions with the advantage of safety for the treatment of malignant tumor bone metastasis.